Results in patients with newly diagnosed APL after treatment with As4S4
| Patient no./age, y/sex . | Days to HCR . | Total As4S4 dose (g) . |
|---|---|---|
| Case 1/32/M | 38 | 37.50 |
| Case 2/34/F | 40 | 37.75 |
| Case 3/48/M | 90 | 145.75 |
| Case 4/21/F | 35 | 60.50 |
| Case 5/29/F | 51 | 98.00 |
| Case 6/16/M | 46 | 105.75 |
| Case 7/29/F | 38 | 110.25 |
| Case 8/37/M | 69 | 89.75 |
| Case 9/41/M | 53 | 141.75 |
| Case 10/20/F | 50 | 94.50 |
| Case 11/35/M | 55 | 135.00 |
| Case 12/43/F | 50 | 150.00 |
| Case 13/22/M | 75 | 97.50 |
| Case 14/63/F | 77 | 186.00 |
| Case 15/42/M | 101 | 312.50 |
| Case 16/29/F | 76 | 221.25 |
| Case 17/32/M | 57 | 193.50 |
| Case 18/26/M | 28 | 105.00 |
| Case 19/41/M | 33 | 138.75 |
| Patient no./age, y/sex . | Days to HCR . | Total As4S4 dose (g) . |
|---|---|---|
| Case 1/32/M | 38 | 37.50 |
| Case 2/34/F | 40 | 37.75 |
| Case 3/48/M | 90 | 145.75 |
| Case 4/21/F | 35 | 60.50 |
| Case 5/29/F | 51 | 98.00 |
| Case 6/16/M | 46 | 105.75 |
| Case 7/29/F | 38 | 110.25 |
| Case 8/37/M | 69 | 89.75 |
| Case 9/41/M | 53 | 141.75 |
| Case 10/20/F | 50 | 94.50 |
| Case 11/35/M | 55 | 135.00 |
| Case 12/43/F | 50 | 150.00 |
| Case 13/22/M | 75 | 97.50 |
| Case 14/63/F | 77 | 186.00 |
| Case 15/42/M | 101 | 312.50 |
| Case 16/29/F | 76 | 221.25 |
| Case 17/32/M | 57 | 193.50 |
| Case 18/26/M | 28 | 105.00 |
| Case 19/41/M | 33 | 138.75 |
For explanation of abbreviations, see Table 1.